Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, April 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Malvern Instruments Shows NanoSight NTA at BioNanoMed 2014
Saturday, March 01, 2014
BioNanoMed 2014 to be held in Krems, Austria from 26 - 28 March.

Unilabs and Diagnoplex SA Announce the Swiss Market Launch of Colox
Saturday, March 01, 2014
A non-invasive colon cancer screening test.

384-Well Reagent Reservoirs from INTEGRA
Friday, February 28, 2014
Reagent reservoirs offer maximum liquid recovery.

Artel Expands Volume Range for Verification of DMSO-based Solutions in Screening Applications
Friday, February 28, 2014
The Artel reagents now cover all volumes less than 10 µL, enabling DMSO solvent-specific volume verification in a real-world setting.

Illumina's verifi® Prenatal Test Significantly Reduces False Positive Rate of Fetal Aneuploidy Detection
Thursday, February 27, 2014
Study results published in New England Journal of Medicine show the verifi® prenatal test achieves positive predictive value tenfold higher than current standard of care.

Biochrom Introduces EZ Nin Reagent for Improved Amino Acid Analysis
Tuesday, February 25, 2014
Ready to use ninhydrin formulation for ion exchange chromatography systems.

Platypus Technologies Launches the New Oris™ Pro 96-Well Invasion Assay
Wednesday, February 19, 2014
New assay for quantitative real-time and end-point measurements of cell invasion.

Lightweight Electronic Pipettes
Tuesday, February 18, 2014
The new VIAFLO II multichannel electronic pipette range from INTEGRA combines ultra lightweight design and unsurpassed operation comfort enabling users to improve efficiency in their working environment.

BioTek's Cytation™ 3 Named Edison Awards Finalist
Saturday, February 15, 2014
Award winners to be announced at the Edison Awards Annual Gala.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 2478
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv